(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...
(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...
Contribute to long-term strategic planning, annual operating plans, and S&OP processes Evaluate new products, services...
Demand & S&OP Planning Lead a global demand planning team for AVS modalities, delivering detailed monthly forecasts... & budgeting processes. Drive problem solving globally. Partner with Planning COE to improve S&OP processes, standardize...
projects. Strong internship/co-op experience if a recent graduate. Previous experience shipping code in high-scale...
Company: Qualcomm Technologies, Inc. Job Area: Engineering Group, Engineering Group >Machine Learning Engineering General Summary: ****Hiring in San Diego and Santa Clara About Qualcomm Robotics Qualcomm Advanced Robotics Team...
Lugar:
San Diego, CA | 25/02/2026 03:02:12 AM | Salario: S/. $158400 - 237600 per year | Empresa:
Qualcomm areas and support other related modules like S&OP, demand management, Planning, Scheduling, PLM, Quality Planning...
Lugar:
Detroit, MI | 22/02/2026 01:02:19 AM | Salario: S/. $168000 - 234000 per year | Empresa:
Infosys integration into the S&OP process and ongoing revenue and margin forecasts. Review business performance across revenue, margin...
Lugar:
New Jersey | 28/01/2026 23:01:52 PM | Salario: S/. $213161 - 231001 per year | Empresa:
Metagenics (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...
(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...